These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8004503)
1. [The role of platelet activating factor in the pathogenesis of asthma]. Péc M; Visnovský P; Dobrota D; Dobiás J; Lazár J Bratisl Lek Listy; 1993 Sep; 94(9):507-9. PubMed ID: 8004503 [TBL] [Abstract][Full Text] [Related]
2. Role for platelet-activating factor in asthma. Chung KF; Barnes PJ Lipids; 1991 Dec; 26(12):1277-9. PubMed ID: 1819715 [TBL] [Abstract][Full Text] [Related]
3. The interaction between PAF, platelets and eosinophils in bronchial asthma. Page CP; Coyle AJ Eur Respir J Suppl; 1989 Jun; 6():483s-487s. PubMed ID: 2679601 [TBL] [Abstract][Full Text] [Related]
4. [Role of platelet activating factor and its antagonists in bronchial asthma]. Massion PB; Frans A Rev Pneumol Clin; 1992; 48(2):49-57. PubMed ID: 1384101 [TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor (PAF) and PAF antagonists in asthma. Hosford D; Mencia-Huerta JM; Braquet P Crit Rev Ther Drug Carrier Syst; 1990; 7(3):261-73. PubMed ID: 2073689 [TBL] [Abstract][Full Text] [Related]
6. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma. Kay AB Eur J Respir Dis Suppl; 1983; 129():1-44. PubMed ID: 6418559 [TBL] [Abstract][Full Text] [Related]
7. Platelet activating factor in allergies. Pałgan K; Bartuzi Z Int J Immunopathol Pharmacol; 2015 Dec; 28(4):584-9. PubMed ID: 26486136 [TBL] [Abstract][Full Text] [Related]
8. [The potential role and mechanism of leukotriene and platelet-activating factor in allergic disease]. Yoshida K; Suko M Nihon Rinsho; 1993 Mar; 51(3):631-7. PubMed ID: 8492436 [TBL] [Abstract][Full Text] [Related]
9. The contribution of platelet-activating factor to allergen-induced eosinophil infiltration and bronchial hyperresponsiveness. Page CP Lipids; 1991 Dec; 26(12):1280-2. PubMed ID: 1819716 [TBL] [Abstract][Full Text] [Related]
10. The effects of hetrazepine PAF antagonists in preclinical models of asthma. Heuer HO Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067 [TBL] [Abstract][Full Text] [Related]
11. [Effect of Asthremedin on bronchial hyperresponsiveness (BHR) to histamine induced by intravenous administration of platelet activating factor (PAF) in guinea pigs]. Tsukagoshi H; Kurosawa M Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Mar; 31(3):310-6. PubMed ID: 8391092 [TBL] [Abstract][Full Text] [Related]
12. Properties of PAF-acether appropriate to a mediator of the inflammatory aspects of asthma. Page CP; Archer CB; Guerreiro D; Morley J Int J Tissue React; 1985; 7(5):351-4. PubMed ID: 4055261 [TBL] [Abstract][Full Text] [Related]
13. [Bronchial hyperresponsiveness to histamine in guinea pig induced by intravenous administration of platelet activating factor]. Tsukagoshi H; Aoki S; Kurosawa M Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1450-5. PubMed ID: 2290229 [TBL] [Abstract][Full Text] [Related]
14. A role for platelet activating factor and platelets in the induction of bronchial hyperreactivity. Page CP Int J Tissue React; 1987; 9(1):27-32. PubMed ID: 3298115 [TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor-induced contraction of human isolated bronchus. Johnson PR; Black JL; Armour CL Eur Respir J; 1992 Sep; 5(8):970-4. PubMed ID: 1426205 [TBL] [Abstract][Full Text] [Related]
17. Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma. Simon HU; Tsao PW; Siminovitch KA; Mills GB; Blaser K J Immunol; 1994 Jul; 153(1):364-77. PubMed ID: 8207248 [TBL] [Abstract][Full Text] [Related]